Implication of high risk Human papillomavirus HR-HPV infection in prostate cancer in Indian population-A pioneering case-control analysis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Singh, Neha ^a,b   Hussain, Showket ^c   Kakkar, Nandita ^d   Singh, Shrawan K ^d   Sobti, Ranbir C ^b   Bharadwaj, Mausumi ^c  

^a UNIVERSITY OF SKÖVDE   (Sweden)

^b PANJAB UNIVERSITY   (India)

^c Institute of Cytology and Preventive Oncology ICMR   (India)

^d POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

AGED; CANCER STAGING; CASE CONTROL STUDY; COMPLICATION; GENETICS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INCIDENCE; INDIA; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATE TUMOR; RISK; SEROTYPING; VIROLOGY;

AGED; CASE-CONTROL STUDIES; DNA, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; INCIDENCE; INDIA; MALE; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATIC NEOPLASMS; RISK; SEROTYPING;

EID: 84929694497     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07822     Document Type: Article

References (38)

1. Tyagi, B., Manoharan, N., Raina, V. A case control study on prostate cancer in Delhi. Asian Pac J Cancer Prev 11, 397-401 (2010).
2. Yeole, B. B. Trends in the prostate cancer incidence in India. Asian Pac J Cancer Prev 9, 141-4 (2008).
3. Center, M. M. et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 61, 1079-92 (2012).
4. Taylor, M. L., Mainous, A. G. 3rd & Wells, B. J. Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med 37, 506-12 (2005).
5. Shavers, V. L., Underwood,W., Moser, R. P. Race/ethnicity and the perception of the risk of developing prostate cancer. Am J Prev Med 37, 64-7 (2009).
6. Zambrano, A., Kalantari, M., Simoneau, A., Jensen, J. L., Villarreal, L. P. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 53, 263-76 (2002).
7. Fioriti, D. et al.A case of human polyomavirus Bk infection in a patient affected by late stage prostate cancer: could viral infection be correlated with cancer progression Int J Immunopathol Pharmacol 20, 405-11 (2007).
8. Kundu, S. D. et al. The toll-like receptor pathway: a novel mechanism of infectioninduced carcinogenesis of prostate epithelial cells. Prostate 68, 223-9 (2008).
9. Sutcliffe, S. et al. Prostate involvement during sexually transmitted infections as measured by prostate-specific antigen concentration. Br J Cancer 105, 602-5 (2011).
10. Wu, J. J., Huang, D. B., Pang, K. R., Tyring, S. K. Cutaneous metastasis to the chest wall from prostate cancer. Int J Dermatol 45, 946-8 (2006).
11. Milde-Langosch, K., Riethdorf, S., Loning, T. Association of human papillomavirus infection with carcinoma of the cervix uteri and its precursor lesions: theoretical and practical implications. Virchows Arch 437, 227-33 (2000).
12. McMurray, H. R., Nguyen, D., Westbrook, T. F., McAnce, D. J. Biology of human papillomaviruses. Int J Exp Pathol 82, 15-33 (2001).
13. Das, B. C., Hussain, S., Nasare, V., Bharadwaj, M. Prospects and prejudices of human papillomavirus vaccines in India. Vaccine 26, 2669-79 (2008).
14. Henderson, B. E., Feigelson, H. S. Hormonal carcinogenesis. Carcinogenesis 21, 427-33 (2000).
15. Adami, H. O., Kuper, H., Andersson, S. O., Bergstrom, R., Dillner, J. Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 12, 872-5 (2003).
16. Aghakhani, A. et al. The role of human papillomavirus infection in prostate carcinoma. Scand J Infect Dis 43, 64-9 (2011).
17. Chen, A. C. et al. Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients. Pathol Oncol Res 17, 613-7 (2011).
18. Lin, Y. et al. Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis. Ir J Med Sci 180, 497-503 (2011).
19. Nayyar, R., Sharma, N., Gupta, N. P. Prognostic factors affecting progression and survival in metastatic prostate cancer. Urol Int 84, 159-63 (2010).
20. Singh, N. et al. Downregulation of tumor suppressor gene PML in uterine cervical carcinogenesis: impact of human papillomavirus infection (HPV). Gynecol Oncol 128, 420-6 (2013).
21. Sobti, R. C. et al. Aberrant promoter methylation and loss of suppressor of cytokine signalling-1 gene expression in the development of uterine cervical carcinogenesis. Cell Oncol (Dordr) 34, 533-43 (2011).
22. Epstein, J. I., Allsbrook, W. C. Jr., Amin, M. B., Egevad, L. L. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29, 1228-42 (2005).
23. Egevad, L., Srigley, J. R., Delahunt, B. International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens: rationale and organization. Mod Pathol 24, 1-5 (2011).
24. Al Moustafa, A. E. Involvement of human papillomavirus infections in prostate cancer progression. Med Hypotheses 71, 209-11 (2008).
25. Gazzaz, F. S.,Mosli, H. A. Lack of detection of human papillomavirus infection by hybridization test in prostatic biopsies. Saudi Med J 30, 633-7 (2009).
26. Hussain, S. et al. Transcription factor AP-1 in esophageal squamous cell carcinoma: alterations in activity and expression during human Papillomavirus infection. BMC Cancer 9, 329 (2009).
27. Hussain, S. et al. Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley. J Recept Signal Transduct Res 31, 147-56 (2011).
28. Thakur, N. et al. Genetic variant of CCND1: association with HPV-mediated cervical cancer in Indian population. Biomarkers 14, 219-25 (2009).
29. Singh, N. et al. Overexpression of signal transducer and activator of transcription (STAT-3 and STAT-5) transcription factors and alteration of suppressor of cytokine signaling (SOCS-1) protein in prostate cancer. J Recept Signal Transduct Res 32, 321-7 (2012).
30. Sobti, R. C. et al. Deregulation of STAT-5 isoforms in the development of HPVmediated cervical carcinogenesis. J Recept Signal Transduct Res 30, 178-88 (2010).
31. Sobti, R. C. et al. Overexpression of STAT3 in HPV-mediated cervical cancer in a north Indian population. Mol Cell Biochem 330, 193-9 (2009).
32. Naghashfar, Z., DiPaolo, J. A.,Woodworth, C. D., Passaniti, A. Immortalization of human adult prostatic adenocarcinoma cells by human papilloma virus HPV16 and 218 DNA. Cancer Lett 100, 47-54 (1996).
33. Anwar, K. et al. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res 52, 5991-6 (1992).
34. Gherdovich, S. et al. [Detection of the human papillomavirus in hyperplastic and cancerous prostatic tissue with PCR]. Minerva Urol Nefrol 49, 73-7 (1997).
35. Leiros, G. J. et al. Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urol 5, 15 (2005).
36. Carozzi, F. et al. Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies. Int J Biol Markers 19, 257-61 (2004).
37. Silvestre, R. V. et al. Low frequency of human papillomavirus detection in prostate tissue from individuals from Northern Brazil. Mem Inst Oswaldo Cruz 104, 665-7 (2009).
38. Tu, H., Jacobs, S. C., Mergner, W. J., Kyprianou, N. Rare incidence of human papillomavirus types 16 and 18 in primary and metastatic human prostate cancer. Urology 44, 726-31 (1994).